Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
Zumiez
ZUMZ
$204M
| $691K | ﹤0.01% |
31,198
-20,438
| -40% | -$498K |
2013 Q2
51 quarters
|
|
2952
Cellebrite
CLBT
$2.78B
| $690K | ﹤0.01% |
50,098
+43,793
| +695% | +$660K |
2023 Q2
11 quarters
|
|
|
GDEN
2953
DELISTED
Golden Entertainment
GDEN
| $690K | ﹤0.01% |
25,836
-20,419
| -44% | -$566K |
2016 Q3
38 quarters
|
|
2954
Ardagh Metal Packaging
AMBP
$2.65B
| $687K | ﹤0.01% |
169,680
-1,614,355
| -90% | -$7.16M |
2022 Q1
16 quarters
|
|
|
CLDT
2955
Chatham Lodging
CLDT
$637M
| $687K | ﹤0.01% |
87,308
-65,703
| -43% | -$489K |
2013 Q2
51 quarters
|
|
2956
Build-A-Bear
BBW
$315M
| $687K | ﹤0.01% |
18,346
-1,034
| -5% | -$54.5K |
2021 Q3
18 quarters
|
|
2957
Unitil
UTL
$934M
| $687K | ﹤0.01% |
13,150
-22,820
| -63% | -$1.17M |
2016 Q1
40 quarters
|
|
2958
Baytex Energy
BTE
$3.24B
| $687K | ﹤0.01% |
153,667
+71,813
| +88% | +$265K |
2023 Q1
12 quarters
|
|
2959
Replimune Group
REPL
$1.23B
| $686K | ﹤0.01% |
89,622
-202,563
| -69% | -$1.55M |
2018 Q3
30 quarters
|
|
2960
Radiant Logistics
RLGT
$439M
| $685K | ﹤0.01% |
97,203
-49,588
| -34% | -$348K |
2017 Q1
36 quarters
|
|
2961
Twin Disc
TWIN
$414M
| $684K | ﹤0.01% |
45,420
+30,968
| +214% | +$523K |
2023 Q3
10 quarters
|
|
2962
Arcutis Biotherapeutics
ARQT
$3.16B
| $682K | ﹤0.01% |
28,965
-302,613
| -91% | -$7.72M |
2022 Q1
16 quarters
|
|
2963
Fulcrum Therapeutics
FULC
$282M
| $678K | ﹤0.01% |
88,458
-44,083
| -33% | -$409K |
2023 Q4
9 quarters
|
|
2964
Tredegar Corp
TG
$245M
| $678K | ﹤0.01% |
85,256
-37,552
| -31% | -$314K |
2016 Q3
38 quarters
|
|
|
VOYG
2965
Voyager Technologies
VOYG
$1.89B
| $677K | ﹤0.01% |
28,946
-5,104
| -15% | -$147K |
2025 Q3
2 quarters
|
|
2966
ARS Pharmaceuticals
SPRY
$405M
| $676K | ﹤0.01% |
84,169
-112,218
| -57% | -$1.08M |
2022 Q1
16 quarters
|
|
2967
Bilibili
BILI
$5.95B
| $675K | ﹤0.01% |
29,903
-36,095
| -55% | -$1.04M |
2018 Q4
29 quarters
|
|
|
AIFC
2968
AI Financial Corp
AIFC
$70.4M
| $674K | ﹤0.01% |
607,304
-76,657
| -11% | -$125K |
2025 Q2
3 quarters
|
|
|
OPLN
2969
Openlane
OPLN
$4.34B
| $672K | ﹤0.01% |
23,051
-141,556
| -86% | -$4.09M |
2013 Q2
51 quarters
|
|
2970
Blue Owl Capital
OBDC
$5.08B
| $671K | ﹤0.01% |
60,674
+9,464
| +18% | +$111K |
2023 Q1
12 quarters
|
|
2971
CytomX Therapeutics
CTMX
$558M
| $669K | ﹤0.01% |
142,412
-194,113
| -58% | -$985K |
2025 Q1
4 quarters
|
|
2972
Bausch Health
BHC
$2.17B
| $668K | ﹤0.01% |
123,783
+103,818
| +520% | +$621K |
2013 Q2
51 quarters
|
|
|
KW
2973
DELISTED
Kennedy-Wilson Holdings
KW
| $667K | ﹤0.01% |
61,631
-139,796
| -69% | -$1.45M |
2013 Q2
51 quarters
|
|
2974
Viemed Healthcare
VMD
$348M
| $666K | ﹤0.01% |
72,277
-59,482
| -45% | -$495K |
2022 Q3
14 quarters
|
|
2975
Shutterstock
SSTK
$141M
| $666K | ﹤0.01% |
40,071
-37,843
| -49% | -$666K |
2013 Q2
51 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.